Quantcast
Last updated on April 16, 2014 at 4:54 EDT

Latest MicroCHIPS Inc. Stories

Image 1 - Osteoporosis Patients Receive Medication From Implanted Microchips
2012-02-17 06:09:52

Seven Dutch women suffering from osteoporosis received bone-strengthening medication from implanted microchips as part of a first-of-its kind study of wirelessly controlled drug-releasing devices, according to research published Thursday in the journal Science Translational Medicine. According to Lauran Neergaard of the Associated Press (AP), the study, which was funded by Massachusetts-based implantable drug delivery device developer MicroCHIPS, Inc and headed up by MIT professors Robert...

2011-03-29 14:13:00

WALTHAM, Mass., March 29, 2011 /PRNewswire/ -- MicroCHIPS, Inc., a developer of innovative drug delivery devices and biosensors, today announced that the U.S. Patent Office and Trademark Office has granted U.S. Patent No. 7,892,221, Method of Controlled Drug Delivery from Implant Device. This patent in conjunction with U.S. Patent No. 7,070,590 provides broad coverage for the design and fabrication of reservoir-based medical devices used for implantable drug delivery systems. MicroCHIPS'...

2011-02-03 08:30:00

BEDFORD, Mass., Feb. 3, 2011 /PRNewswire/ -- MicroCHIPS, Inc., a developer of innovative drug delivery systems, is initiating the first clinical study to demonstrate precisely controlled delivery of a peptide from a multi-reservoir, programmable, implant system. The study will assess the pharmacokinetics of long-term parathyroid hormone (hPTH 1-34) delivery in women with osteoporosis. Parathyroid hormone is a thirty-four amino acid peptide that is currently self-injected daily to...

2010-04-30 08:09:00

BEDFORD, Mass., April 30 /PRNewswire/ -- MicroCHIPS, Inc., a developer of intelligent implant systems, today announced that it has received a 2010 Edison Best New Product Award(TM) for its Illume(TM) product. The product was awarded Gold in the Science and Medical Category, recognizing the benefit that it will bring to millions of people with diabetes who must manage their blood sugar intensively to stay healthy. "We are very honored to receive this award, as it demonstrates our innovative...

2010-04-13 07:00:00

BEDFORD, Mass., April 13 /PRNewswire/ -- MicroCHIPS, Inc., a developer of intelligent implant systems, has announced the appointment of Ajit S. Gill as President and Chief Executive Officer. Mr. Gill, most recently CEO of Auspex Pharmaceuticals, is best known for his leadership of Nektar Therapeutics, a company he grew from a start-up to a public biopharmaceutical company. "We are very pleased that Ajit is joining MicroCHIPS," said Terry McGuire, co-founder and general partner at Polaris...

2010-01-07 08:00:00

BEDFORD, Mass., Jan. 7 /PRNewswire/ -- MicroCHIPS, Inc., a developer of intelligent implant systems, has raised $16.5 million to fund its lead programs in diabetes and osteoporosis. Current investors Polaris Venture Partners, Novartis Venture Fund, Flybridge Capital Partners, Medtronic, Saints Capital, Intersouth Partners, Care Capital and CSK Venture Capital were joined by new investor InterWest Partners. "Support from our investors enables us to bring our vision to life," said John...

2009-12-03 08:00:00

BEDFORD, Mass., Dec. 3 /PRNewswire/ -- MicroCHIPS, a developer of intelligent, responsive implant systems, today announced it has been named a 2010 Technology Pioneer by the World Economic Forum. The company was selected for pioneering a novel medical device platform that uses patented, responsive implants designed to bridge the gap between disease monitoring and treatment. MicroCHIPS' technologies have broad applicability, from 'rescue' applications in diabetes and cardiology, where...

2009-01-06 10:32:00

BEDFORD, Mass., Jan. 6 /PRNewswire/ -- MicroCHIPS, Inc., a developer of intelligent implanted devices, has named Massachusetts General Hospital endocrinologist, Robert M. Neer, MD, to its Scientific Advisory Board. MicroCHIPS' has partnered with prominent clinicians to form a Scientific Advisory Board to support the company's innovative biosensing and drug delivery programs in diabetes, osteoporosis and other chronic diseases. As a leading physician and researcher in osteoporosis, Dr. Neer...